Abstract
Saudi Food and Drug Authority (SFDA) established the Proactive Drug Safety Monitoring Program to monitor the safety of registered medicinal products in Saudi Arabia more proactively and efficiently. The Proactive Drug Safety Monitoring Program evaluated the relatedness of adverse drug event (ADE) case reports exported from VigiBase, the World Health Organization global database of individual case safety reports, with a group of medications approved by SFDA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
